<DOC>
	<DOCNO>NCT01612364</DOCNO>
	<brief_summary>This double-blind randomized control trial evaluate efficacy sympathetic block via thoracic vertebra T3 treatment CRPS I upper limb . Patients CRPS I refractory medical treatment subject four physical therapy session randomize experimental control block four physiotherapy session . Patients evaluate one month blockade ( primary outcome ) 12 month . Will evaluate analgesic scale ( Mcgill , brief pain inventory , dn4 questionnaire , NPSI , VAS ) , functional ( ADM ) quality life ( HAD WHOQOL-brief ) .</brief_summary>
	<brief_title>RCT : Thoracic Sympathetic Block Treatment Complex Regional Pain Syndrome I Upper Limb</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<criteria>Complex regional pain syndrome ( IASP , 1994 ) involve upper limb ; Pain score excess five visual analog scale ( VAS ) ; Poor outcome treatment ( le 50 % reduction VAS score ) History severe brain injury , epilepsy stroke Patients undergone sympathetic ganglion block treatment affect limb , technique Severe systemic disease Addictive behavior , severe psychiatric disorder , psychiatric disease untreated Refusal participate initial adherence orientation Refusal randomize treatment group contraindication pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>CRPS I</keyword>
</DOC>